Compare FVRR & TOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FVRR | TOI |
|---|---|---|
| Founded | 2010 | 2007 |
| Country | Israel | United States |
| Employees | N/A | 641 |
| Industry | Business Services | Medical/Nursing Services |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 366.3M | 304.4M |
| IPO Year | 2019 | N/A |
| Metric | FVRR | TOI |
|---|---|---|
| Price | $10.53 | $3.29 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 3 |
| Target Price | ★ $18.43 | $6.67 |
| AVG Volume (30 Days) | 722.9K | ★ 1.9M |
| Earning Date | 04-29-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $30.15 |
| Revenue Next Year | $1.83 | $25.77 |
| P/E Ratio | $22.05 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.67 | $1.80 |
| 52 Week High | $34.13 | $4.88 |
| Indicator | FVRR | TOI |
|---|---|---|
| Relative Strength Index (RSI) | 47.56 | 57.64 |
| Support Level | $10.25 | $2.79 |
| Resistance Level | $11.26 | $3.74 |
| Average True Range (ATR) | 0.42 | 0.23 |
| MACD | 0.19 | -0.00 |
| Stochastic Oscillator | 81.48 | 74.66 |
Fiverr International Ltd operates a online marketplace that enables sellers to offer digital services and buyers to purchase them The Company's platform features an extensive catalog of digital services that spans over hundreds of categories. Buyers can purchase digital services ranging from simple services such as logo design and blog post writing, to complex services such as video creation, website development and social media marketing. Also, the Company offers value-added services including subscription products, advertising solutions and financial tools designed to support marketplace users and enhance their business activities. The company generates maximum of its revenue from USA.
The Oncology Institute Inc offers oncology care and treatment services to patients through several clinics located across the United States. It offers services such as infusion chemotherapy, oral drug chemotherapy, hospice and palliative care, autologous stem cell transplants, outpatient blood product transfusions, patient navigator programs, radiation oncology, and others on a fee or value-based model. Additionally, the company enrolls patients in clinical trials, where appropriate. The company has three operating segments: Specialty Pharmacy, Patient Services, and Clinical Trials and Other. Maximum revenue is generated from the Specialty Pharmacy segment, which operates specialty and retail pharmacies providing IV-infused, oral, injectable, and other medications for oncology treatment.